Is SGRY undervalued or overvalued?
As of 2025-03-16, the Intrinsic Value of Surgery Partners Inc (SGRY) is 33.82 USD. This SGRY valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 23.60 USD, the upside of Surgery Partners Inc is 43.30%. This means that SGRY is undervalued by 43.30%.
The range of the Intrinsic Value is 21.75 - 56.53 USD
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 21.75 - 56.53 | 33.82 | 43.3% |
| DCF (Growth 10y) | 31.71 - 68.21 | 44.43 | 88.3% |
| DCF (EBITDA 5y) | 11.31 - 20.14 | 15.73 | -33.4% |
| DCF (EBITDA 10y) | 20.68 - 30.43 | 25.49 | 8.0% |
| Fair Value | -6.61 - -6.61 | -6.61 | -128.02% |
| P/E | (18.04) - 18.83 | (2.10) | -108.9% |
| EV/EBITDA | (4.06) - 27.19 | 12.65 | -46.4% |
| EPV | 23.88 - 28.16 | 26.02 | 10.2% |
| DDM - Stable | (10.18) - (28.96) | (19.57) | -182.9% |
| DDM - Multi | 9.17 - 20.94 | 12.83 | -45.6% |
| Market Cap (mil) | 2,999.80 |
| Beta | 0.97 |
| Outstanding shares (mil) | 127.11 |
| Enterprise Value (mil) | 6,100.60 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.60% |
| Cost of Debt | 7.23% |
| WACC | 7.28% |